VEGFA and neoplasm: Regarding the role of MDSCs in the resistance to anti-angiogenic therapy, it was reported that tumors refractory to VEGF blockade contained increased numbers of tumor-infiltrating CD11b+Gr-1+ MDSCs in mouse models [69,70].